Synthesis and evaluation of tripodal peptide analogues for cellular delivery of phosphopeptides

Journal of Medicinal Chemistry

Volumn 50, Issue 15, 2007, Pages 3604-3617

  Ye, Guofeng ^a   Nam, Nguyen Hai ^a   Kumar, Anil ^a   Saleh, Ali ^a   Shenoy, Dinesh B ^b   Amiji, Mansoor M ^b   Lin, Xiaofeng ^a   Sun, Gongqin ^a   Parang, Keykavous ^a  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCEIN; LINEAR PEPTIDE DERIVATIVE; PEPTIDE DERIVATIVE; PHOSPHOPEPTIDE; PHOSPHOTYROSINE; PROTEIN SH2; TRIPODAL PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL MEMBRANE; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOSOL; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE POLARIZATION; HUMAN; HUMAN CELL; PEPTIDE SYNTHESIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SRC HOMOLOGY DOMAIN;

CELL LINE, TUMOR; CELL MEMBRANE; CELL SURVIVAL; CYTOSOL; DENDRIMERS; DRUG CARRIERS; ELECTRICITY; FLOW CYTOMETRY; FLUORESCENCE POLARIZATION; HUMANS; MOLECULAR CONFORMATION; OSMOLAR CONCENTRATION; PEPTIDES, CYCLIC; PHOSPHOPEPTIDES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 34547592118     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm070416o     Document Type: Article

References (43)

1. Langel, U., Ed. Handbook of Cell-Penetrating Peptides; CRC Press: Boca Raton, FL, 2007.
2. El-Andaloussi, S.; Holm, T.; Langel, U. Cell-penetrating peptides: Mechanisms and applications. Curr. Pharm. Des. 2005, 11, 3597-3611.
3. Fotin-Mleczek, M.; Fischer, R.; Brock, R. Endocytosis and cationic cell-penetrating peptides, a merger of concepts and methods. Curr. Pharm. Des 2005, 11, 3613-3628.
4. Fernandez-Carneado, J.; Kogan, M. J.; Pujals, S.; Giralt, E. Amphipathic peptides and drug delivery. Biopolymers 2004, 76, 196-203.
5. Deshayes, S.; Morris, M. C.; Divita, G.; Heitz, F. Cell-penetrating peptides: tools for intracellular delivery of therapeutics. Cell Mol. Life Sci. 2005, 62, 1839-1849.
6. Stiriba, S. E.; Frey, H.; Haag, R. Dendritic polymers in biomedical applications: from potential to clinical use in diagnostics and therapy. Angew. Chem., Int. Ed. Engl. 2002, 41, 1329-1334.
7. Wimmer, N.; Marano, R. J.; Kearns, P. S.; Rakoczy, E. P.; Toth, I. Syntheses of polycationic dendrimers on lipophilic peptide core for complexation and transport of oligonucleotides. Bioorg. Med. Chem. Lett. 2002, 12, 2635-2637.
8. Aoki, S.; Kimura, E. Recent progress in artificial receptors for phosphate anions in aqueous solution. Rev. Mol. Biotechnol. 2002, 90, 129-155.
9. Rothbard, J. B.; Kreider, E.; VanDeusen, C. L.; Wright, L.; Wylie, B. L.; Wender, P. A. Arginine-rich molecular transporters for drug delivery: role of backbone spacing in cellular uptake. J. Med. Chem. 2002, 45, 3612-3618.
10. Fischer, P. M.; Krausz, E.; Lane, D. P. Cellular delivery of impermeable effector molecules in the form of conjugates with peptides capable of mediating membrane translocation. Bioconjugate Chem. 2001, 12, 825-841.
11. Lindgren, M. E.; Haellbrink, M. M.; Elmquist, A. M.; Langel, U. Passage of cell-penetrating peptides across a human epithelial cell layer in vitro. Biochem. J. 2004, 377, 69-76.
12. Frankel, A. D.; Pabo, C. O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988, 55, 1189-1193.
13. Bhorade, R.; Weissleder, R.; Nakakoshi, T.; Moore, A.; Tung, C.-H. Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-Tat derived membrane translocation peptide. Bioconjugate Chem. 2000, 11, 301-305.
14. Josephson, L.; Tung, C. H.; Moore, A.; Weissleder, R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjugate Chem. 1999, 10, 186-191.
15. Fawell, S.; Seery, J.; Daikh, Y.; Moore, C.; Chen, L. L.; Pepinsky, B.; Barsoum, J. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 664-668.
16. Mitchell, D. J.; Kim, D. T.; Steinman, L.; Fathman, C. G.; Rothbard, J. B. Polyarginine enters cells more efficiently than other polycationic homopolymers. J. Pept. Res. 2000, 56, 318-325.
17. Futaki, S.; Suzuki, T.; Ohashi, W.; Yagami, T.; Tanaka, S.; Ueda, K.; Sugiura, Y. Arginine-rich peptides: an abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 2001, 276, 5836-5840.
18. Wender, P. A.; Mitchell, D. J.; Pattabiraman, K.; Pelkey, E. T.; Steinman, L.; Rothbard, J. B. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl. Acad. Science U.S.A. 2000, 97, 13003-13008.
19. Wender, P. A.; Jessop, T. C.; Pattabiraman, K.; Pelkey, E. T.; VanDeusen, C. L. An efficient, scalable synthesis of the molecular transporter octaarginine via a segment doubling strategy. Org. Lett. 2001, 3, 3229-3232.
20. Umezawa, N.; Gelman, M. A.; Haigis, M. C.; Raines, R. T.; Gellmann, S. H. Translocation of a β-peptide across cell membranes. J. Am. Chem. Soc. 2002, 124, 368-369.
21. Rueping, M.; Mahajan, Y.; Sauer, M.; Seebach, D. Cellular uptake studies with β-peptides. ChemBioChem 2002, 3, 257-259.
22. Wender, P. A.; Rothbard, J. B.; Jessop, T. C.; Kreider, E. L.; Wylie, B. L. Oligocarbamate molecular transporters: design, synthesis, and biological evaluation of a new class of transporters for drug delivery. J. Am. Chem. Soc. 2002, 124, 13382-13383.
23. Futaki, S.; Niwa, M.; Nakase, I.; Tadokoro, A.; Zhang, Y.; Nagaoka, M.; Wakako, N.; Sugiura, Y. Arginine carrier peptide bearing Ni(II) chelator to promote cellular uptake of histidine-tagged proteins. Bioconjugate Chem. 2004, 15, 475-481.
24. Rothbard, J. B.; Jessop, T. C.; Lewis, R. S.; Murray, B. A.; Wender, P. A. Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells. J. Am. Chem. Soc. 2004, 126, 9506-9507.
25. Gras-Masse, H. Lipid vector for the delivery of peptides towards intracellular pharmacological targets. J. Mol. Recognit. 2003, 16, 234-239.
26. Trehin, R.; Merkle, H. P. Chances and pitfalls of cell penetrating peptides for cellular drug delivery. Eur. J. Pharm. Biopharm. 2004, 58, 209-223.
27. Songyang, Z.; Shoelson, S. E.; Chaudhuri, M.; Gish, G.; Pawson, T.; Haser, W. G.; King, F.; Roberts, T.; Ratnofsky, S.; Lechleider, R. J.; Neel, B. G.; Birge, R. B.; Fajardo, J.-E.; Chou, M. M.; Hanafusa, H.; Schaffhausen, B.; Cantley, L. C. SH2 domains recognize specific phosphopeptide sequences. Cell 1993, 72, 767-778.
28. Burke, T. R.; Yao, Z.-J.; Liu, D.-G.; Voigt, J.; Gao, Y. Phosphoryltyrosyl mimetics in the design of peptide-based signal transduction inhibitors. Biopolymers 2001, 60, 32-44.
29. Eck, M. J. A new flavor in phosphotyrosine recognition. Structure 1995, 3, 421-424.
30. Pinna, L. A.; Donella-Deana, A. Phosphorylated synthetic peptides as tools for studying protein phosphatases. Biochim. Biophys. Acta 1994, 1222, 415-431.
31. Ottinger, E. A.; Shekels, L. L.; Bernlohr, D. A.; Barany, G. Synthesis of phosphotyrosine-containing peptides and their use as substrates for protein tyrosine phosphatases. Biochemistry 1993, 32, 4354-4361.
32. Zhou, Y.; Abagyan, R. How and why phosphotyrosine-containing peptides bind to the SH2 and PTB domains. Folding Des. 1998, 3, 513-522.
33. Machida, K.; Mayer, B. J. The SH2 domain: versatile signaling module and pharmaceutical target. Biochim. Biophys. Acta 2005, 1747, 1-25.
34. Dunican, D. J.; Doherty, P. Designing cell-permeant phosphopeptides to modulate intracellular signaling pathways. Biopolymers 2001, 60, 45-60.
35. Williams, E. J.; Dunican, D. J.; Green, P. J.; Howell, F. V.; Derossi, D.; Walsh, F. S.; Doherty, P. Selective inhibition of growth factor-stimulated mitogenesis by a cell-permeable Grb2-binding peptide. J. Biol. Chem. 1997, 272, 22349-22354.
36. Derossi, D.; Williams, E. J.; Green, P. J.; Dunican, D. J.; Doherty, P. Stimulation of mitogenesis by a cell-permeable PI 3-kinase binding peptide. Biochem. Biophys. Res. Commun. 1998, 251, 148-152.
37. Theodore, L.; Derossi, D.; Chassaing, G.; Llirbat, B.; Kubes, M.; Jordan, P.; Chneiweiss, H.; Godement, P.; Prochiantz, A. Intraneuronal delivery of protein kinase C pseudosubstrate leads to growth cone collapse. J. Neurosci. 1995, 15, 7158-7167.
38. Waksman, G.; Kominos, D.; Robertson, S. C.; Pant, N.; Baltimore, D.; Birge, R. B.; Cowburn, D.; Hanafusa, H.; Mayer, B. J.; Overduin, M.; Resh, M. D.; Rios, C. B.; Silverman, L.; Kuriyan, J. Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature 1992, 358, 646-653.
39. Nam, N.-H.; Ye, G.; Sun, G.; Parang, K. Conformationally constrained peptide analogues of pTyr-Glu-Glu-Ile as inhibitors of the Src SH2 domain binding. J. Med. Chem. 2004, 47, 3131-3141.
40. Lynch, B. A.; Loiacono, K. A.; Tiong, C. L.; Adams, S. E.; MacNeil, I. A. A fluorescence polarization based Src-SH2 binding assay. Anal. Biochem. 1997, 247, 77-82.
41. Sandvig, K.; Olsnes, S. Entry of the toxic proteins abrin, modeccin, ricin, and diphtheria toxin into cells. II. Effect of pH, metabolic inhibitors, and ionophores and evidence for toxin penetration from endocytotic vesicles. J. Biol. Chem. 1982, 257, 7504-7513.
42. Derossi, D.; Calvet, S.; Trembleau, A.; Brunissen, A.; Chassaing, G.; Prochintz, A. Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J. Biol. Chem. 1996, 271, 18188-18193.
43. Fischer, R.; Waizenegger, T.; Kohler, K.; Brock, R. A quantitative validation of fluorophore-labelled cell-permeable peptide conjugates: fluorophore and cargo dependence of import. Biochim. Biophys. Acta 2002, 1564, 365-374.